Health Care & Life Sciences » Pharmaceuticals | Canadian International Pharma Corp.

Canadian International Pharma Corp. | Balance Sheet

Fiscal year is November-October. All values CAD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
15.70
13.40
10.20
291.30
145.00
Total Accounts Receivable
1.40
0.00
4.20
4.90
4.20
Other Current Assets
1.30
1.30
5.80
15.80
20.70
Total Current Assets
18.40
14.70
20.20
312.00
169.90
Total Investments and Advances
-
5.00
5.00
5.00
5.00
Other Assets
1,336.20
933.20
-
-
-
Total Assets
1,354.60
952.90
25.20
317.00
174.90
ST Debt & Current Portion LT Debt
25.00
125.00
-
-
-
Accounts Payable
305.80
-
-
-
26.50
Other Current Liabilities
0.00
178.80
53.70
23.70
89.30
Total Current Liabilities
330.80
303.80
53.70
23.70
115.80
Long-Term Debt
-
-
100.00
-
-
Total Liabilities
330.80
303.80
153.70
23.70
115.80
Common Equity (Total)
1,023.80
649.10
128.50
293.40
59.10
Total Shareholders' Equity
1,023.80
649.10
128.50
293.40
59.10
Total Equity
1,023.80
649.10
128.50
293.40
59.10
Liabilities & Shareholders' Equity
1,354.60
952.90
25.20
317.00
174.90

About Canadian International Pharma

View Profile
Address
2489 Bellevue Avenue
West Vancouver British Columbia V7V 1E1
Canada
Employees -
Website http://www.canpharmacorp.ca
Updated 09/14/2018
Canadian International Pharma Corp. is a pharmaceutical company, which engages is in the process of developing generic and nutraceutical drug manufacturing, distribution, and sales. It offers PharmaCert, a certification program for testing and measuring finished dosage forms of nutraceutical and pharmaceutical medications. The company was founded on November 21, 1983 and is headquartered in West Vancouver, Canada.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.